These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19283527

  • 1. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation.
    Chanvorachote P, Pongrakhananon V, Wannachaiyasit S, Luanpitpong S, Rojanasakul Y, Nimmannit U.
    Cancer Invest; 2009 Jul; 27(6):624-35. PubMed ID: 19283527
    [Abstract] [Full Text] [Related]

  • 2. Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation.
    Pongrakhananon V, Nimmannit U, Luanpitpong S, Rojanasakul Y, Chanvorachote P.
    Apoptosis; 2010 May; 15(5):574-85. PubMed ID: 20127174
    [Abstract] [Full Text] [Related]

  • 3. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells.
    Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, Castranova V, Rojanasakul Y.
    Mol Pharmacol; 2008 Jan; 73(1):119-27. PubMed ID: 17911532
    [Abstract] [Full Text] [Related]

  • 4. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 5. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells.
    Kuhar M, Sen S, Singh N.
    Anticancer Res; 2006 Jan; 26(2A):1297-303. PubMed ID: 16619537
    [Abstract] [Full Text] [Related]

  • 6. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination.
    Chanvorachote P, Nimmannit U, Stehlik C, Wang L, Jiang BH, Ongpipatanakul B, Rojanasakul Y.
    Cancer Res; 2006 Jun 15; 66(12):6353-60. PubMed ID: 16778213
    [Abstract] [Full Text] [Related]

  • 8. Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway.
    Sen S, Sharma H, Singh N.
    Biochem Biophys Res Commun; 2005 Jun 17; 331(4):1245-52. PubMed ID: 15883009
    [Abstract] [Full Text] [Related]

  • 9. Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells.
    Yu Z, Shah DM.
    Gynecol Oncol; 2007 Sep 17; 106(3):541-8. PubMed ID: 17590421
    [Abstract] [Full Text] [Related]

  • 10. Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy.
    Mańdziuk S, Dudzisz-Sledź M, Korszeń-Pilecka I, Milanowski J, Wojcierowski J, Korobowicz E.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Sep 17; 58(1):149-53. PubMed ID: 15314975
    [Abstract] [Full Text] [Related]

  • 11. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
    Gu T, Ohashi R, Cui R, Tajima K, Yoshioka M, Iwakami S, Sasaki S, Shinohara A, Matsukawa T, Kobayashi J, Inaba Y, Takahashi K.
    Lung Cancer; 2009 Nov 17; 66(2):176-83. PubMed ID: 19285749
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D, Pratscher B, Soutschek J, Geick A, Vornlocher HP, Müller M, Wacheck V.
    Anticancer Drugs; 2007 Aug 17; 18(7):755-61. PubMed ID: 17581297
    [Abstract] [Full Text] [Related]

  • 13. Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A-induced apoptosis in A549.
    Wang B, Feng Y, Song X, Liu Q, Ning Y, Ou X, Yang J, Zhang X, Wen F.
    Toxicology; 2009 Apr 28; 258(2-3):176-83. PubMed ID: 19428937
    [Abstract] [Full Text] [Related]

  • 14. XIAP-mediated protection of H460 lung cancer cells against cisplatin.
    Cheng YJ, Jiang HS, Hsu SL, Lin LC, Wu CL, Ghanta VK, Hsueh CM.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):75-84. PubMed ID: 19903469
    [Abstract] [Full Text] [Related]

  • 15. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells].
    Cheng XD, Cai SX, Zhao HJ, Li WJ, Tong WC.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar 10; 28(3):389-91. PubMed ID: 18359697
    [Abstract] [Full Text] [Related]

  • 16. Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradation.
    Park K, Lee JH.
    Oncol Rep; 2009 Mar 10; 21(3):689-92. PubMed ID: 19212627
    [Abstract] [Full Text] [Related]

  • 17. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M, Louis MH, Dutoit S, Brotin E, Lincet H, Duigou F, Staedel C, Gauduchon P, Poulain L.
    Gynecol Oncol; 2007 Apr 10; 105(1):31-44. PubMed ID: 17275076
    [Abstract] [Full Text] [Related]

  • 18. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T, Zhou L, Wang T, Xu J, Wang J, Chen W, Zhou X, Huang Z, Zhu W, Shu Y, Liu P.
    Int J Mol Med; 2013 Sep 10; 32(3):593-8. PubMed ID: 23856992
    [Abstract] [Full Text] [Related]

  • 19. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells.
    Cho Y, Park MJ, Park M, Min SS, Yee J, Kim C, Han MS, Han SH.
    Respirology; 2009 Aug 10; 14(6):850-8. PubMed ID: 19703066
    [Abstract] [Full Text] [Related]

  • 20. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
    Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV.
    Cancer Res; 2005 Jun 15; 65(12):5301-9. PubMed ID: 15958577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.